Trending Stock News

EPS for Netflix, Inc. (NFLX) Expected At $0.63; Synergy Pharmaceuticals (SGYP) Sentiment Is 1.22

Analysts expect Netflix, Inc. (NASDAQ:NFLX) to report $0.63 EPS on April, 16.They anticipate $0.23 EPS change or 57.50% from last quarter’s $0.4 EPS. NFLX’s profit would be $273.39 million giving it 119.42 P/E if the $0.63 EPS is correct. After having $0.41 EPS previously, Netflix, Inc.’s analysts see 53.66% EPS growth. The stock decreased 1.88% or $5.76 during the last trading session, reaching $300.94. About 9.53 million shares traded. Netflix, Inc. (NASDAQ:NFLX) has risen 75.34% since March 24, 2017 and is uptrending. It has outperformed by 58.64% the S&P500.

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. The company has market cap of $458.79 million. The Company’s lead product is plecanatide, a novel uroguanylin analog that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. It currently has negative earnings. The firm also develops dolcanatide to treat mild-to-moderate ulcerative colitis.

Great Point Partners Llc holds 1.85% of its portfolio in Synergy Pharmaceuticals Inc. for 3.27 million shares. Trellus Management Company Llc owns 362,500 shares or 1.44% of their US portfolio. Moreover, Cheyne Capital Management (Uk) Llp has 0.68% invested in the company for 1.63 million shares. The Japan-based Hikari Power Ltd has invested 0.56% in the stock. Orbimed Advisors Llc, a New York-based fund reported 13.62 million shares.

The stock decreased 2.62% or $0.05 during the last trading session, reaching $1.86. About 3.18 million shares traded. Synergy Pharmaceuticals Inc. (SGYP) has risen 24.44% since March 24, 2017 and is uptrending. It has outperformed by 7.74% the S&P500.

Analysts await Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) to report earnings on May, 9. They expect $-0.16 EPS, up 46.67% or $0.14 from last year’s $-0.3 per share. After $-0.18 actual EPS reported by Synergy Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts -11.11% EPS growth.

Ratings analysis reveals 67% of Synergy Pharma’s analysts are positive. Out of 3 Wall Street analysts rating Synergy Pharma, 2 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. SGYP was included in 3 notes of analysts from December 23, 2016. The firm has “Sell” rating by Citigroup given on Thursday, April 6. Rodman & Renshaw maintained it with “Buy” rating and $17.0 target in Friday, December 23 report. Oppenheimer initiated the stock with “Outperform” rating in Thursday, January 5 report.

Netflix, Inc., an Internet television network, engages in the Internet delivery of television shows and movies on various Internet-connected screens. The company has market cap of $130.59 billion. It operates in three divisions: Domestic Streaming, International Streaming, and Domestic DVD. It has a 240.75 P/E ratio. The firm offers TV shows and movies, including original series, documentaries, and feature films.

Investors sentiment increased to 1.31 in 2017 Q3. Its up 0.19, from 1.12 in 2017Q2. It is positive, as 56 investors sold Netflix, Inc. shares while 255 reduced holdings. 115 funds opened positions while 233 raised stakes. 356.10 million shares or 3.23% more from 344.96 million shares in 2017Q2 were reported. Thrivent Financial For Lutherans holds 0.54% in Netflix, Inc. (NASDAQ:NFLX) or 837,907 shares. Virginia Retirement Systems Et Al has invested 0.23% in Netflix, Inc. (NASDAQ:NFLX). The Montana-based First Interstate State Bank has invested 0.01% in Netflix, Inc. (NASDAQ:NFLX). North Star Investment Mngmt Corp reported 0.02% stake. Salem Investment Counselors Inc has 0.33% invested in Netflix, Inc. (NASDAQ:NFLX). Lord Abbett And Ltd Liability stated it has 380,763 shares. Jpmorgan Chase & Company stated it has 0.11% of its portfolio in Netflix, Inc. (NASDAQ:NFLX). Advisors Asset Incorporated accumulated 3,758 shares. Boys Arnold invested 0.07% in Netflix, Inc. (NASDAQ:NFLX). 546,999 are held by Adage Cap Partners Grp Limited Liability Corporation. Fisher Asset Management Limited Liability Corporation holds 0% in Netflix, Inc. (NASDAQ:NFLX) or 2,111 shares. Jefferies Group Inc Ltd Liability owns 9,189 shares for 0.01% of their portfolio. 4,924 were reported by Group Incorporated One Trading Ltd Partnership. 1,995 were accumulated by Heritage Mngmt. Wexford Cap L P holds 0.02% or 1,137 shares.

Since October 2, 2017, it had 0 insider buys, and 39 insider sales for $157.72 million activity. Another trade for 11,264 shares valued at $3.01 million was made by HOAG JAY C on Wednesday, January 31. $437,545 worth of Netflix, Inc. (NASDAQ:NFLX) was sold by FRIEDLAND JONATHAN on Thursday, January 11. BARTON RICHARD N also sold $392,320 worth of Netflix, Inc. (NASDAQ:NFLX) shares. Peters Gregory K had sold 8,274 shares worth $2.48 million. $191,200 worth of Netflix, Inc. (NASDAQ:NFLX) was sold by WELLS DAVID B on Monday, December 18. $17.00M worth of stock was sold by HASTINGS REED on Monday, January 22. SARANDOS THEODORE A had sold 163,747 shares worth $43.05 million on Thursday, February 8.

Among 56 analysts covering Netflix (NASDAQ:NFLX), 39 have Buy rating, 2 Sell and 15 Hold. Therefore 70% are positive. Netflix had 232 analyst reports since August 4, 2015 according to SRatingsIntel. Bernstein maintained the stock with “Buy” rating in Friday, March 9 report. The firm has “Outperform” rating given on Tuesday, April 19 by Cowen & Co. The rating was maintained by Robert W. Baird on Tuesday, October 17 with “Hold”. The stock of Netflix, Inc. (NASDAQ:NFLX) has “Buy” rating given on Tuesday, June 20 by Guggenheim. On Friday, October 13 the stock rating was maintained by RBC Capital Markets with “Buy”. The company was maintained on Tuesday, April 19 by Robert W. Baird. BMO Capital Markets maintained the shares of NFLX in report on Monday, September 11 with “Hold” rating. On Tuesday, September 5 the stock rating was maintained by Canaccord Genuity with “Buy”. Evercore upgraded the shares of NFLX in report on Tuesday, December 6 to “Hold” rating. As per Tuesday, July 19, the company rating was maintained by Citigroup.

Leave a Reply

Your email address will not be published. Required fields are marked *